Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription


4 AJR Am J Roentgenol
1 Am J Pathol
1 Biochem Biophys Res Commun
1 BMC Gastroenterol
1 Br J Surg
1 Cancer
6 Dig Dis Sci
5 Gastroenterology
4 Hepatology
2 J Gastroenterol
3 J Hepatol
2 PLoS One
2 Radiology
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

    Editorial Comment: Intravascular Ultrasound Facilitates TIPS Creation.
    AJR Am J Roentgenol. 2022;219:646.

  2. RONOT M
    Editorial Comment: The Influence of Steatosis on Liver Stiffness Measurement-A Call for Caution, but Limited Clinical Consequences.
    AJR Am J Roentgenol. 2022;219:613.

  3. KUMADA T, Toyoda H, Yasuda S, Ogawa S, et al
    Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
    AJR Am J Roentgenol. 2022;219:604-612.
    PubMed         Abstract available

  4. TSE JR, Felker ER, Cao JJ, Naini BV, et al
    Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    AJR Am J Roentgenol. 2022 Sep 28. doi: 10.2214/AJR.22.28233.
    PubMed         Abstract available

    Am J Pathol

  5. JIAO J, Jiang Y, Qian Y, Liu G, et al
    Expression of STING is increased in monocyte-derived macrophages and contributes to liver inflammation in hepatic ischemia-reperfusion injury.
    Am J Pathol. 2022 Sep 26. pii: S0002-9440(22)00285.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  6. SUN TT, Liu XL, Yang GY, Zhang W, et al
    Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis.
    Biochem Biophys Res Commun. 2022;630:167-174.
    PubMed         Abstract available

    BMC Gastroenterol

  7. LI Z, Gao H, Zhang X, Liu Q, et al
    Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
    BMC Gastroenterol. 2022;22:427.
    PubMed         Abstract available

    Br J Surg

  8. PENG W, Zhang X, Li C, Zhu X, et al
    Programmed cell death protein 1 and tyrosine kinase inhibition plus transcatheter arterial chemoembolization of advanced hepatocellular carcinoma.
    Br J Surg. 2022 Sep 27. pii: 6718210. doi: 10.1093.


  9. CAO M, Li H, Sun D, He S, et al
    Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study.
    Cancer. 2022;128:3653-3662.
    PubMed         Abstract available

    Dig Dis Sci

    MAFLD Versus NAFLD: Which Better Predicts the Risk of Atherosclerotic Cardiovascular Disease?
    Dig Dis Sci. 2022;67:4606-4608.

  11. KIM H, Lee CJ, Ahn SH, Lee KS, et al
    MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups.
    Dig Dis Sci. 2022;67:4919-4928.
    PubMed         Abstract available

  12. GIRI S, Darak H, Kasturi S
    Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious.
    Dig Dis Sci. 2022;67:4962-4964.

  13. ASHOURI Y, Hsu CH, Riall TS, Konstantinidis IT, et al
    Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Liver Failure After Resection of Colorectal Liver Metastases.
    Dig Dis Sci. 2022;67:4950-4958.
    PubMed         Abstract available

  14. BENSON M, Gopal D, Pfau P
    Electronic Health Record Work Demands for Gastroenterology and Hepatology Providers: A Prospective Use Analysis and Survey Study.
    Dig Dis Sci. 2022 Sep 28. pii: 10.1007/s10620-022-07691.
    PubMed         Abstract available

  15. SINGH A, De A, Singh MP, Rathi S, et al
    Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.
    Dig Dis Sci. 2022 Sep 25. pii: 10.1007/s10620-022-07641.
    PubMed         Abstract available


  16. DARA L
    No Necroptosis in Hepatocytes: The Final Nail in the Coffin?
    Gastroenterology. 2022 Sep 22. pii: S0016-5085(22)01083.

  17. BAJAJ JS, Nagy LE
    Natural History of Alcohol-Associated Liver Disease: Understanding the Changing Landscape of Pathophysiology and Patient Care.
    Gastroenterology. 2022;163:840-851.
    PubMed         Abstract available

  18. SHINGINA A, Sarkar M, Feld L
    On the Importance of Safe Access to Reproductive Options for Adolescents and Women With Liver Disease.
    Gastroenterology. 2022;163:792-794.

  19. AJMERA V, Kim BK, Yang K, Majzoub AM, et al
    Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
    Gastroenterology. 2022;163:1079-1089.
    PubMed         Abstract available

  20. BEHARI J
    Needle-free Nonalcoholic Fatty Liver Disease Prognostication: Moving One Step Closer.
    Gastroenterology. 2022;163:819-822.


  21. VIZZUTTI F, Celsa C, Battaglia S, Miraglia R, et al
    Reply to the Letter to the Editor: "Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis - does novelty supplant the standard?"
    Hepatology. 2022 Sep 30. doi: 10.1002/hep.32813.

  22. VAZ K, Little R, Majeed A, Roberts S, et al
    Letter to the Editor: Predicting mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis - does novelty supplant the standard?
    Hepatology. 2022 Sep 28. doi: 10.1002/hep.32811.

    NGAL in AKI and cirrhosis - ready for prime time?
    Hepatology. 2022 Sep 28. doi: 10.1002/hep.32807.

  24. YIP TC, Wong VW, Wong GL
    Does hepatic steatosis impact chronic hepatitis B?
    Hepatology. 2022 Sep 24. doi: 10.1002/hep.32803.

    J Gastroenterol

  25. SATAKE T, Morizane C, Rikitake R, Higashi T, et al
    The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    J Gastroenterol. 2022 Sep 26. pii: 10.1007/s00535-022-01920.
    PubMed         Abstract available

  26. HANAI T, Nishimura K, Miwa T, Maeda T, et al
    A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
    J Gastroenterol. 2022 Sep 29. pii: 10.1007/s00535-022-01925.
    PubMed         Abstract available

    J Hepatol

  27. WANG Y, Hu M, Yang H
    Cirrhosis is an independent predictor for COVID-19 mortality: A meta-analysis of confounding cofactors-controlled data.
    J Hepatol. 2022 Sep 27. pii: S0168-8278(22)03122.

  28. REINIS J, Petrenko O, Simbrunner B, Hofer BS, et al
    Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03119.
    PubMed         Abstract available

  29. FAGAN A, Gavis EA, Gallagher ML, Mousel T, et al
    A double-blind randomized placebo-controlled trial of albumin in patients with hepatic encephalopathy: HEAL study.
    J Hepatol. 2022 Sep 21. pii: S0168-8278(22)03116.
    PubMed         Abstract available

    PLoS One

  30. KANN AE, Ba-Ali S, Seidelin JB, Larsen FS, et al
    The effect of induced hyperammonaemia on sleep and melanopsin-mediated pupillary light response in patients with liver cirrhosis: A single-blinded randomized crossover trial.
    PLoS One. 2022;17:e0275067.
    PubMed         Abstract available

  31. SITTHIRACH C, Charoensuk L, Pairojkul C, Chaidee A, et al
    Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini.
    PLoS One. 2022;17:e0275273.
    PubMed         Abstract available


  32. EMMONS EC, Bishay S, Du L, Krebs H, et al
    Survival and Toxicities after (90)Y Transarterial Radioembolization of Metastatic Colorectal Cancer in the RESIN Registry.
    Radiology. 2022;305:228-236.
    PubMed         Abstract available

  33. DUAN L, Zhang B, Zheng X
    Restratification of Advanced Hepatocellular Carcinoma to Identify Patients Sensitive to Transarterial Chemoembolization.
    Radiology. 2022 Sep 27:221149. doi: 10.1148/radiol.221149.


  34. THULUVATH AJ, Siddiqui O, Lai JC, Peipert J, et al
    Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation.
    Transplantation. 2022 Sep 29. pii: 00007890-990000000-00176.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.